COX-2 and prostaglandins in atherosclerosis

Abstract

Arachidonic acid metabolism is involved in acute ischemic syndromes affecting the coronary or cerebrovascular territory, as demonstrated by biochemical measurements of eicosanoid biosynthesis and the results of inhibitor trials in these settings. In particular, the efficacy of low-dose aspirin in reducing the complications of acute ischemic syndromes has focused attention on the cyclooxygenase (COX) pathway of arachidonic acid metabolism and its products, collectively termed prostanoids.

Two cyclooxygenase (COX)-isozymes have been characterized, COX-1 and COX-2, that differ in terms of regulatory mechanisms of expression, tissue distribution, substrate specificity and preferential coupling to upstream and downstream enzymes. While the role of platelet COX-1 in acute ischemic diseases is firmly established, the role of COX-2 in atherothrombosis is still uncertain. Studies from our group suggest that variable expression of upstream and downstream enzymes in the prostanoid biosynthesis may represent important determinants of the functional consequences of COX-2 expression and inhibition in different clinical settings.

Keywords

atherosclerosis COX-2 inflammation prostaglandins

Get full access to this article

View all access options for this article.

References

Cipollone F , Prontera C , Pini B et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability . Circulation 2001; 104: 921-927 .

Brash AR. Arachidonic acid as a bioactive molecule . J Clin Invest 2001; 107: 1339-1345 .

Inoue T , Takayanagi K , Morooka S et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis . Thromb Haemost 2001; 85: 165-170 .

Straus DS , Pascual G , Li M et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway . Proc Natl Acad Sci USA 2000; 97: 4844-4849 .

Rossi A , Kapahi P , Natoli G et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase . Nature 2000; 403: 103-108 .

Ricote M , Li AC , Willson TM , Kelly CJ , Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation . Nature 1998; 391: 79-82 .

Shibata T , Kondo M , Osawa T , Shibata N , Kobayashi M , Uchida K. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes . J Biol Chem 2002; 12: 10459-10466 .

Eguchi Y , Eguchi N , Oda H et al. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients . Proc Natl Acad Sci USA 1997; 94: 14689-14694 .

Fournier T , Fadok V , Henson PM. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis . J Biol Chem 1997; 272: 31065-31072 .

10.

Garcia-Fernandez LF , Iniguez MA , Eguchi N , Fresno M , Urade Y , Munoz A. Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells . J Neurochem 2000; 75: 460-470 .

11.

Cipollone F , Fazia M , Iezzi A et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans . Arterioscler Thromb Vasc Biol 2004; 24: 1259-1265 .

12.

Takayama K , Garciá-Cardeña G , Sukhova GK , Comander J , Gimbrone MA Jr , Libby P. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor . J Biol Chem 2002; 277: 44147-44154 .

13.

McCoy JM , Wicks JR , Audoly LP. The roleofprostaglandin E2receptors in the pathogenesis of rheumatoid arthritis . J Clin Invest 2002; 110: 651-658 .

14.

Miyaura C , Inada M , Suzawa T et al. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice . J Biol Chem 2000; 275: 19819-19823 .

15.

Cipollone F , Fazia M , Iezzi A et al. The prostaglandin E receptor subtype EP4 mediates PGE2-dependent plaque instability in humans . Eur Heart J 2003; 24: 416-416 .

16.

Faour WH , He Y , He QW et al. Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts . J Biol Chem 2001; 276: 31720-31731 .

17.

Matsumoto H , Naraba H , Murakami M et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages . Biochem Biophys Res Commun 1997; 230: 110-114 .